Extensive Biotechnological Changes with Seattle Genetics

In January 2013 the biotechnology company Seattle Genetics selected Clay Siegall, Ph. D., as a director external of the Board of Directors. Siegall is also the co-founder, President, Chief Executive Officer and Chairman of Board of Director of the company. His scientific inventiveness has instituted meticulous research and practices in drug development for Seattle Genetics and patients needing treatment. The company developed ADCETRIS (brentuximab vedotin) that has been approved by the U.S. Food and Drug Administration (FDA) under his direction. Dr. Clay Siegall is also the author of 70 publications and possess 15 patents. His educational background consists of a Ph. D. in Genetics and a B.S. in Zoology.

Dr. Siegall founded Seattle Genetics in 1998 and has assembled antibody-based therapies for cancer patients. His successful drive for integrating medical advancements with biotechnology has impressively and generously led to developing antibody-drug conjugates (ADCs). These ADCs are presently used for cancer treatment. This remarkable accomplishment has been incorporated across internal and collaborator programs that use the company’s technology. He has guided investments coordinating capital growth for the company and earned more than $330 million. The appointment as an outside director of the company’s Board of Directors will benefit the development of microRNA (miRNA) therapeutics which are innovated by another biotechnology company called Mirna.

The function of miRNAs is influencing gene phenotype appearance by interacting with emissary RNAs. This enables miRNAs to control and harmonize cellular pathways in multiple processes effectively and efficiently. The responsibility encompasses embryonic development, immunity, inflammation, and cellular growth. Resulting in patient well-being from preventing the growth and incidence of cancer along with the diffusion of it. Poorly structured miRNAs in tumor cells are also interchanged for maximum benefits.

Mirna has been focusing on service advancement and commercialization for using its biotechnology in miRNA therapeutics. Studies in oncology-directed miRNAs amplify dominance over cancer tumors and resulted in clinical conquest of dissimilar animal studies. The company has hopeful anticipation of moving forward with the promotion of Dr. Clay Siegall because of plausible teamwork expansions with Seattle Genetics. The shared passion for cancer treatment between the companies will assist biotechnology to further integrate with the cancer treatment field constructively. The newfound team collaboration supplies cancer treatments with a positive outlook.




Norka Luque, A Musician With True Talent

Norka Luque is an exceptional musical craftsman who resides in Miami, Florida (Fort Lauderdale). She performs music from the pop, urban, Latin and move classifications. Luque runs her own particular autonomous record mark called “NorkaMusic Productions LLC.” She discharges her music through this name. Her present administrator is Alberto Gomez from Light Concepts PR.

Norka Luque adored singing as far back as she was a youthful tyke at four years old. She has been taking part innumerous rivalries about sing. After she had finished her secondary school training, she went to France to seek after her four year college education in Business Administration. She likewise graduated with degrees in showcasing, style and additionally twisting expressions.

She recollects each moment that she was given a melody, and she could feel like she required anything to take into the music for a minute and keep in touch with her fantasy that smoldered harder in her. She chose to join a band in France by the name Bad Moon Rising. This gathering went about as a learning knowledge where she learnt how to sing as a soloist.

It was not until four years prior when she met with the maker Emilio Estefan. This was the point at which she had returned to the United States and began taking lessons in music when she met with him. She had no clue that he would be available and that he would be occupied with his music and ability. She drew closer and talked with him and gave him her music undertaking and she was astounded that he preferred the music.

He then set out set for make Norka a star with a few practice sessions that made her turn out with something new to take in each time she was rehearsing. Norka’s enthusiasm is to sing music that will have a genuine would like to the general population that listen to the melodies.

Luque’s wellbeing got ugly in 2014 because of epilepsy. It is a neurological condition that dissues with the cerebrum’s nerve cell exercises. She had cerebrum surgery in mid-2015. The surgery persevered through a somewhat troublesome and burdening mending process. Regardless of every last bit of her battles, she’s currently arranging a noteworthy rebound. Fito Blanko has delivered her fresh out of the box new single.

Despite battling epilepsy, Norka still continues to inspire thousands with her music. She sees the bigger picture to produce for her fans. Norka is on social media as well as having her music available for download.

Seattle Genetics Focus On Helping Individuals That Suffer From Debilitating Illnesses

Seattle Genetics is a biotechnology company that focuses on what is lacking in oncology. Many children and adults suffer from debilitating diseases that can be offset or avoided by stem cell research. A recent PRN News article has named Seattle Genetics as one of the fastest growing pharmaceutical companies in the industry. They understand there are a large number of people that have unmet medical needs. They are focused on the development and commercialization of microRNA (miRNA). They are the industry leaders in monoclonal antibodies and antibody-drug conjugates. Seattle Genetics continues to be a successful oncology provider and helping to heal thousands of people across the world annually.

Clay Siegall is the co-founder of Seattle Genetics and under his leadership they have become one of the most successful healthcare providers of antibody-drugs that are attacking agents that are killing the cells that lead to a lot of diseases and illnesses. Siegall has also helped earn a huge portion of financing to continue the valuable research into stem research. Building a successful oncology team increases the value of miRNA and micro-RNA based therapeutics. They also have a broad pipeline of other product brands that will treat illness and disease.

Seattle Genetics works closely with Takeda and has full commercialization rights to ADCETRIS. They put the needs of the patients first and want to provide a gateway for their patients that need oncology. Therapeutics is a safer method to cure or aid in many diseases that are affecting the daily lives of millions of people. They offer a wide program of services that will help you take back your life and get the productivity out of living everyday and being able to do the things that they use to or always wanted to do.

Micro-RNA are still in the early stages of research and Seattle Genetics with Clay Siegall depends on the generous donations of many people that make stem cell and oncology research possible. Their most popular feature is their clinical program that reduces the affects of the side affects of chemotherapy. You’re invited to visit their website for more details and information on their services and programs at Seattle Genetics.




Rajiv K Fernando: an Inspiration

Rajiv K Fernando, or “Raj” as he prefers, is unbelievably successful businessman and philanthropist, as well as a prominent fundraiser and donor for the Democratic Party. He is the current CEO of Scoutahead.com, former founder/CEO of Chopper Trading and former head of the State Department’s International Security Advisory Board.

Raj Fernando was born in 1971 to CK and Laura Fernando in Denmark. He was born the youngest out of three siblings, and moved to the United States at the age of 1-year-old. He attended both the University College of London and Beloit College where he obtained bachelor’s degrees history and economics.

After graduating college, Fernando worked hard at the lowest level of the Chicago Mercantile Exchange, and ultimately moved his way up to the very top of the ladder. He held several positions at the Chicago Board of Trade, and in 2002 Mr. Fernando created the famously successful Chopper Trading, that thrives to this very day under new ownership. While he was CEO of Chopper Trading, Mr. Fernando single-handedly fashioned some of the most sophisticated corporate security risk management ideas into reality, which addressed many safety issues regarding all aspects of the financial industry.

At present, Fernando serves as developer and CEO of Scoutahead.com, a company trusted by the masses to enhance personal and corporate prosperity and fluidity. He has more than a decade of wisdom and experience that greatly benefits the many of the companies, boards, charities and organizations in which he serves.

Adding to his extensive accomplishments and lengthy resume are several noteworthy areas of service. Fernando serves on the Board of Directors for the Chicago Symphony Orchestra as well as on the Board of Directors of PAWS Chicago, a no-kill animal shelter. He is an enthusiastic supporter of the Big Brothers Big Sisters organization, The Steppenwolf Theatre, the Illinois Holocaust Museum and Cedars-Sinai Medical Center. Politically, Mr. Fernando is a well-known fundraiser for the Democratic Party and has raised significant funds for both the President Obama and Hilary Clinton campaigns, and he is an enthusiastic supporter of and donor to the Clinton Foundation, to which he has donated between $100,000 and $250,000.

In conclusion, employees of Raj Fernando say that he is a kind, considerate, fair and loyal employer who counteracts their stress-levels from working in such a volatile industry with places of rest, exercise, and relaxation within their work environments. He is dearly loved.

Talk Fusion – Empowering and Giving Back

Talk Fusion offers the world’s very first all-in-one video marketing solution. This video marketing solution was designed with businesses in mind and to help them increase profits as well as keep their customers returning time and time again. Talk Fusion recently won the 2016 Communications Solution Product of the Year Award from the Technology Marketing Corporation. This award was designed to honor the outstanding services available on the market today that offer voice, video, and data communications solutions. The CEO and founder of Talk Fusion Bob Reina was very excited to receive this award and gave credit and gratitude to the talented IT team behind it all. He has also assured the world that their all in one video marketing solution is just the beginning of what is to come from Talk Fusion.

Talk Fusion is a leading global entity that is providing marketing services to businesses of all sizes across the world allowing them to increase their profits and gain a loyal customer base. The company was founded upon giving back to the community and they have partnered with many different charities and animal causes to give back to the community in the countries they work in around the world. Whether you are looking for video email services, video newsletters, live meeting platforms, video chat or personalized sign-up forms, Talk Fusion has services and products to help.

Talk Fusion currently provides services to businesses in over 140 countries worldwide and are giving back to the community in all of them through charities and helping empower individuals to follow their dreams.

Source: http://www.prnewswire.com/news-releases/talk-fusion-video-chat-wins-2016-communications-solutions-product-of-the-year-award-300315095.html?tc=eml_cleartime

Additional Sources:



Clay B. Siegall Takes Up A New Role As An Outside Director At Mirna Therapeutics

Clay B. Siegall, Ph.D. is a co-founder, CEO and Chairman of Board of Directors of Seattle Genetics. In January 30, 2013, Clay was appointed to serve as an outside director to Mirna’s Board of Directors. Mirna Therapeutics is a biotechnology firm dealing with development and commercialization of mirna. Dr. Paul Lammers, President and CEO of Mirna, expressed his excitement for the inclusion of the new member. He said that the company was looking forward to benefiting from Siegall’s extensive experience in the pharmaceutical industry.

Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
About microRNAs
miRNAs are global gene expression natural regulators encoded to the human genome. They are 20-25 nucleotides long and work by interacting with messenger RNAs. miRNAs regulate and coordinate several cellular processes and pathways since a single miRNA is able to regulate the expression of tens-hundreds of different genes. They also play several roles including facilitating proper embryonic development, cellular growth as well as proliferation, immunity and inflammation.
About Mirna Therapeutics
This is a biotechnological company founded in 2007. It is located in Austin, Texas. The pharmaceutical firm deals with development and commercialization of miRNAs, which are developed by in-house scientists and other in-licensed scientists from different institutions. Among the 300 miRNAs in its IP portfolio are key cancer tumor suppressors, miR-34 and let-7. These suppressors have proven to stop the growth of tumor in several animals. Mirna’s source of funds includes private investors, the State of Texas and the Research Institute of Texas. To view the original source of this information, go to the link below.
About Dr. Clay B. Siegall
In 1998, Dr. Siegall co-founded Seattle Genetics. Over the years, he has helped the company build a diverse channel of therapies based on antibody to deal with unattended needs of cancer patients. In August 2011, the company’s first commercial product, ADCETRIS® was approved. The entity has also collaborated with top biotechnology and pharmaceutical firms, earning over $675 million via public and private funding. Clay is an active member of the Board of Directors for Alder Biopharmaceuticals. Previously, he worked for Bristol-Myers Squibb Pharmaceutical Research Institute and National Cancer Institutes of Health. The author of over 70 publications went to George Washington University and the University of Maryland where he earned his PhD in Genetics and received a B.S. in zoology respectively.



Seattle Genetics and Clay Siegall, their CEO


Seattle Genetics is a biotechnology company which has been based in Washington for a while. It is the industry leader in antibody drug conjugates that focuses on developing and commercializing new antibody based therapies for the treatment of cancer. Traditional chemotherapy helps fight cancer effectively if it has been arrested early enough. However, apart from acting on active cancer cells, it also acts on active healthy cells hence some of the disastrous effects of chemotherapy and the fear of it.

Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors

These side effects of chemotherapy can be treated by following up treatment by more treatment which is harmful to the body.A class of drugs have been developed and tested to innovate treatment of cancer that have fewer side effects. Antibody drug conjugates are an example of this treatment that are meant to target only active cancer cells and in the process diminish the side effects of traditional chemotherapy. Antibody drug conjugates are coupled with an antibody that works with a specific target tumor marker that can be only fund in cancer cells. These antibodies track the tumor and attach themselves to the surface of the cancer cells in the same way that white bold cells would attach to bacteria. This leads to a biochemical reaction that sees the cancerous cells ingested by the antibodies and in the process killing the cancer. Seattle Genetics’ lead program is called ADCETRIS®, also referred to as BrentuximabVedotin.

Seattle Genetics collaborated with Takeda Pharmaceutical Company and has made available this technology to 65 countries including the United States, Canada, Japan and several members of the European Union. This treatment is commercially available for relapsed Hodgkin lymphoma as well as relapsed systemic anaplastic large cell lymphoma. Seattle Genetics is conducting a thorough clinical development program with three studies to evaluate the potential of this technology in many other types of lymphomas.Seattle Genetics is a public company incorporated in 1998 who’s CEO and chairman is Clay Siegall. He is a renowned scientist with wide experience in the area of oncology research. He has a Bachelor of Science – Zoology from the University of Maryland and a PhD in Genetics from George Washington University.



Frank Ocean Continues The Trend of Event Releases With “Boys Don’t Cry”

The music industry is constantly evolving, trying to keep up with consumers who are buying less and streaming more. Gone are the days of announcing an albums release date, and promoting it for months with MTV appearances, music videos, and late night performances. Instead, high profile artists like Beyoncé make their album releases a multimedia event, giving fans more than just a batch of songs to listen to on their iPod or cell phone. And that’s exactly what hip-hop star Frank Ocean has elected to do with his new album Boys Don’t Cry.

Ocean has teamed up with Apple to offer fans a companion publication to go alongside his new album, which is scheduled for release on August 5th. Following in the footsteps of Drake and Kanye West, Ocean is set to release Boys Don’t Cry with very little prior notice. This tactic certainly paid off for Drizzy and Yeezus; dropping an album in this fashion all but guarantees that it gets the majority of attention from the entertainment media, as well as music fans. Although you have to wonder, has Frank Ocean reached that level of stardom? I wouldn’t be shocked if this album is the one that brings him the overwhelming mainstream success that he deserves.

It will be very interesting to see how well Boys Don’t Cry performs, given the unique and high profile nature of its release. One thing’s for sure, it’s already become one of the most anticipated albums of 2016.

Frank Ocean Releasing New Album

Frank Ocean To Release “Boys Don’t Cry” This Week

Frank Ocean will finally be releasing his next album on Apple Music. This Friday, the album called “Boys Don’t Cry” will hit stores.

The announcement regarding the album came after an Apple Music-hosted live stream video on Ocean’s personal website, which featured an empty room complete with work benches and some background noises to fill it out. The event itself only took place after Ocean kept dropping hints over and over, mainly in July when he posted a picture with a list of potential release dates for the album. Then his brother Ryan confirmed that a date in July of 2016 would be the day for a release.

Ocean already told media sources that the album was dubbed “Boys Don’t Cry” but hadn’t officially clarified the title. Of course, he had been working heavily on this project since 2013, with several big name producers including Pharrell Williams, Danger Mouse, Rodney Jerkins and Hit-Boy. Back in December of 2014, rapper Lil B even posted an Instagram photo with him and Ocean in the studio.

This new album would be Ocean’s first real album since he dropped “Channel Orange” back in 2012, although he released a track called “Memrise” in November of 2014 only on Soundcloud. Also in his spare time, he wrote a ballad for Quentin Tarantino’s 2012 hit film “Django Unchained” called “Wise Man,” though the song unfortunately wasn’t included since Tarantino couldn’t find a proper fit for the song.

We’re All Somebody From Somewhere Lets Us Down

Steven Tyler, the legendary singer from Aerosmith, decided to take a stab at country music on his latest album. His new album, We’re All Somebody From Somewhere, is a collection of 15 tracks. On nearly all of them, Tyler is trying his hardest to transform into a romantic balladeer. The effort is not without rewards. Tyler provides the listener with a nice remake of “Janie’s Got Her Gun.” Tyler also gives us a glimpse of his trademark dirty side on “Red, White, & You.” However, that is the only song that really lets the listener know they are listening to the lovably sleazy Steven Tyler. The rest of the songs on the album seem to be desperately attempting to keep that side of Tyler, essentially the only side of Tyler we all know and love, in check.

What’s a listener to do with such an approach to an album? If We’re All Somebody From Somewhere was released by an unknown artist, it would likely be received warmly and mark the start of a modest and promising career. Unfortunately, Steven Tyler is anything but an unknown, and his attempt to keep his ego in check on these tracks feels disappointing. It’s like Tyler moved next door to you, and you are disappointed to discover he’s just a regular guy who likes to walk the dog, mow the lawn, and be in bed by nine. If Tyler is going to go country, we expect more of his trademark style.